ATE252636T1 - Klonierung und expression von dem beta app-c100 rezeptor - Google Patents

Klonierung und expression von dem beta app-c100 rezeptor

Info

Publication number
ATE252636T1
ATE252636T1 AT93921283T AT93921283T ATE252636T1 AT E252636 T1 ATE252636 T1 AT E252636T1 AT 93921283 T AT93921283 T AT 93921283T AT 93921283 T AT93921283 T AT 93921283T AT E252636 T1 ATE252636 T1 AT E252636T1
Authority
AT
Austria
Prior art keywords
cloning
receptor
expression
beta
app
Prior art date
Application number
AT93921283T
Other languages
English (en)
Inventor
Susan P Manly
Michael R Kozlowski
Rachael L Neve
Original Assignee
Bristol Myers Squibb Co
Mclean Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co, Mclean Hospital Corp filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ATE252636T1 publication Critical patent/ATE252636T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Neurology (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Plant Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT93921283T 1992-08-31 1993-08-31 Klonierung und expression von dem beta app-c100 rezeptor ATE252636T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93818492A 1992-08-31 1992-08-31
US08/114,555 US5854392A (en) 1992-08-31 1993-08-30 β APP-C100 receptor
PCT/US1993/008229 WO1994005811A1 (en) 1992-08-31 1993-08-31 CLONING AND EXPRESSION OF βAPP-C100 RECEPTOR

Publications (1)

Publication Number Publication Date
ATE252636T1 true ATE252636T1 (de) 2003-11-15

Family

ID=25471035

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93921283T ATE252636T1 (de) 1992-08-31 1993-08-31 Klonierung und expression von dem beta app-c100 rezeptor

Country Status (12)

Country Link
US (1) US5854392A (de)
EP (1) EP0659217B1 (de)
JP (1) JPH08500491A (de)
AT (1) ATE252636T1 (de)
AU (1) AU689441B2 (de)
CA (1) CA2143325C (de)
DE (1) DE69333261T2 (de)
ES (1) ES2208643T3 (de)
FI (1) FI950883A (de)
HU (1) HUT70456A (de)
NZ (1) NZ256188A (de)
WO (1) WO1994005811A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083713A (en) * 1992-08-31 2000-07-04 Bristol-Myers Squibb Company Cloning and expression of βAPP-C100 receptor (C100-R)
AUPN649395A0 (en) * 1995-11-10 1995-12-07 Ramsay Health Care Pty Ltd A method for diagnosing alzheimer's disease
WO1998040495A1 (en) * 1997-03-13 1998-09-17 Beth Israel Deaconess Medical Center Inc. Doublin, a gene involved in neuronal development and uses therefor
EP0971952A2 (de) * 1997-04-10 2000-01-19 Royal Netherlands Academy of Arts and Sciences Diagnoseverfahren und reagenzien
US5952217A (en) * 1997-09-23 1999-09-14 Bristol-Myers Squibb Company Recombinant yeast cell and assay using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675285A (en) * 1984-09-19 1987-06-23 Genetics Institute, Inc. Method for identification and isolation of DNA encoding a desired protein

Also Published As

Publication number Publication date
NZ256188A (en) 1997-01-29
EP0659217A1 (de) 1995-06-28
EP0659217B1 (de) 2003-10-22
DE69333261D1 (de) 2003-11-27
US5854392A (en) 1998-12-29
DE69333261T2 (de) 2004-08-05
HUT70456A (en) 1995-10-30
WO1994005811A1 (en) 1994-03-17
CA2143325C (en) 2004-02-17
ES2208643T3 (es) 2004-06-16
JPH08500491A (ja) 1996-01-23
HU9500619D0 (en) 1995-04-28
AU4843493A (en) 1994-03-29
FI950883A (fi) 1995-04-28
EP0659217A4 (de) 1997-03-12
CA2143325A1 (en) 1994-03-17
FI950883A0 (fi) 1995-02-27
AU689441B2 (en) 1998-04-02

Similar Documents

Publication Publication Date Title
ATE177757T1 (de) Verbesserte immunogene zusammensetzung gegen mensliches gastrin 17
BR0215281A (pt) Compostos de succinimida heterocìclicos fundidos e seus análogos, moduladores da função do receptor de hormÈnio nuclear
BRPI9605663B8 (pt) Bis (resorcinil) triazinas.
DE69232537D1 (de) Rezeptoren der steroid/thyroid superfamilie von rezeptoren
PT98710A (pt) Processo de preparacao de compostos de indolilo substituidos e de composicoes farmaceuticas que os contem
ATE169031T1 (de) Zellrezeptor spezifische monoklonale antikörper gegen stammzell-faktor-rezeptor
MX9707021A (es) Receptor de il-7.
DK0909315T3 (da) CCK-2, en receptortyrosinkinase
DK0695171T3 (da) Lyosfærer indeholdende gonadotropin
ATE214610T1 (de) Neuartige pharmazeutische verwendungen von krill- enzymen
DK0851926T3 (da) Varianter af humant rekombinant gamminterferon (rhu-IFN-gamma) med forøget termisk stabilitet
ATE107853T1 (de) Orales, melatonin enthaltendes arzneimittel.
ATE252636T1 (de) Klonierung und expression von dem beta app-c100 rezeptor
MX9102518A (es) Dicarbonatos y uretanos de acido 4,5,-dihidroxi y 4,5,8,-trihidroxi-9,10-dihidro-9,10-dioxi-2-1-antracencarboxilico que tiene actividad terapeutica.
ATE92542T1 (de) Azeotropaehnliche zusammensetzungen von 1,1dichlor-2,2,2-trifluoraethan und 1,1-dochlor-1fluor|than.
ES8105975A1 (es) Procedimiento para la obtencion de nuevos carbamatos
PT80221A (en) Improved process for preparing benzamide derivatives useful as anticonvulsant agents
DK0729740T3 (da) Anvendelse af guldlegeringer til konstruktionselementer i dentalteknikken
DE69623464D1 (de) Modifizierte kojibioside analoge
ATE87314T1 (de) Platin-arzneimittel.
IL119412A (en) Gonadotropins and pharmaceutical compositions containing them
MY106292A (en) (alpha)-adrenergic receptor antagonists.
ES8102565A1 (es) Procedimiento para la obtencion de 2-fenilamino-imidazolinas-(2)sustituidos
TR200000916T2 (tr) İkameli piperidin türevleri.
IT8721615A0 (it) Clonaggio del gene dell'isoamilasi.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0659217

Country of ref document: EP

REN Ceased due to non-payment of the annual fee